$ Value
$0
Shares
44,000
Price
$0
Filed
Jun 13
Insider
Name
Graves Adrienne L
Title
—
CIK
0001326192
Roles
Transaction Details
Transaction Date
2025-06-11
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
44,000
Footnotes
On June 11, 2025, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Company"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date. | Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date.
Filing Info
Graves Adrienne L's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-20 | IRD | A | $0 |
| 2026-01-01 | IRD | A | — |
| 2025-06-20 | HROW | A | $0 |
| 2025-06-11 | OCUL | A | $0 |
| 2025-06-11 | OCUL | A | $0 |
| 2025-04-30 | IRD | A | $0 |
| 2025-04-30 | IRD | A | $0 |
Other Insiders at OCUL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| LINDSTROM RICHARD L MD | $461K | — | 2026-02-20 |
|
Heier Jeffrey S.
Chief Scientific Officer
|
— | $25K | 2026-02-23 |
|
Dugel Pravin
See Remarks
|
— | $1.3M | 2026-04-09 |
|
Notman Donald
Chief Operating Officer
|
— | $205K | 2026-02-12 |
|
Kaiser Peter
Chief Development Officer
|
— | $23K | 2026-02-23 |
|
Nayak Sanjay
Chief Strategy Officer
|
— | $108K | 2026-02-23 |
|
Waheed Nadia
Chief Medical Officer
|
— | $98K | 2026-02-20 |
|
Robinson David Wayne
Global CCO
|
— | — | 2026-01-21 |